aspartic acid has been researched along with ritonavir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, LE; Clemente, JC; Dunn, BM; Goodenow, MM; Hemrajani, R | 1 |
| George Priya Doss, C; Purohit, R; Rajasekaran, R; Ramanathan, K; Rao, S; Sudandiradoss, C | 1 |
| Al-Amodi, O; Beigel, F; Caesar, J; Gropp, R; Holdt, L; Jodeleit, H; Siebeck, M; Villarroel Aguilera, C | 1 |
3 other study(ies) available for aspartic acid and ritonavir
| Article | Year |
|---|---|
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N.
Topics: Alanine; Anti-HIV Agents; Asparagine; Aspartic Acid; Binding Sites; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoleucine; Kinetics; Methionine; Mutagenesis, Site-Directed; Nelfinavir; Ritonavir; Valine | 2003 |
Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants.
Topics: Amino Acid Sequence; Aspartic Acid; Binding Sites; HIV Protease; HIV Protease Inhibitors; HIV-1; Molecular Conformation; Molecular Sequence Data; Mutation; Protein Binding; Protein Conformation; Ritonavir; Sequence Homology, Amino Acid; Solvents | 2008 |
Targeting ulcerative colitis by suppressing glucose uptake with ritonavir.
Topics: Adult; Aged, 80 and over; Animals; Aspartic Acid; Biomarkers; CD4-Positive T-Lymphocytes; Colitis, Ulcerative; Disease Models, Animal; Female; Glucose; Glutamic Acid; Humans; Inflammation; Leukocytes; Male; Middle Aged; Phenotype; Principal Component Analysis; Ritonavir | 2018 |